NASTI CHRISTIAN

Bartoli, F., Calabrese, A., Moretti, F., Castiglioni, M., Prestifilippo, L., De Pietra, A., et al. (2024). Exploring depression in people with schizophrenia spectrum disorders: A cross-sectional analysis of the clinical relationship with Positive and Negative Syndrome Scale dimensions. REVISTA BRASILEIRA DE PSIQUIATRIA [10.47626/1516-4446-2023-3418]. Dettaglio

Bartoli, F., Bachi, B., Callovini, T., Palpella, D., Piacenti, S., Morreale, M., et al. (2024). Anxious distress in people with major depressive episodes: a cross-sectional analysis of clinical correlates. CNS SPECTRUMS, 29(1), 49-53 [10.1017/S1092852923002377]. Dettaglio

Ostuzzi, G., Gastaldon, C., Tettamanti, M., Cartabia, M., Monti, I., Aguglia, A., et al. (2024). Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial. ECLINICALMEDICINE, 69(March 2024) [10.1016/j.eclinm.2024.102491]. Dettaglio

Bartoli, F., Nasti, C., Palpella, D., Piacenti, S., Di Lella, M., Mauro, S., et al. (2023). Characterizing the clinical profile of mania without major depressive episodes: a systematic review and meta-analysis of factors associated with unipolar mania. PSYCHOLOGICAL MEDICINE, 53(15), 7277-7286 [10.1017/S0033291723000831]. Dettaglio

Bartoli, F., Cavaleri, D., Nasti, C., Palpella, D., Guzzi, P., Riboldi, I., et al. (2023). Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 13(January-December 2023) [10.1177/20451253231163682]. Dettaglio